CVS Caremark Plan Looks to Nix Costs for Diabetes Drugs
Sydney Otomancek2023-11-15T16:56:50-05:00February 3rd, 2020|Categories: Featured, HEOR Feature, Industry News|Tags: CVS, CVS Caremark, diabetes, RxZERO|
CVS Caremark's newest option, RxZERO, looks to nix out-of-pocket costs for diabetes drugs through a number of strategies, including nudging [...]
CVS Caremark’s foray into cost-effectiveness analysis raises questions about the future of prescription medicines in America
C T2023-11-15T17:53:20-05:00September 25th, 2018|Categories: Blog, Featured, HEOR Feature, Industry News|Tags: Catherine Stevenson, Cost Effectiveness Analysis, CVS Caremark, drug pricing, Healtheconomics.com, ICER, Patti Peeples, PBM, QALY, tHEORetically Speaking, value based pricing|
Written By: Americans spend more on prescription drugs than anyone else in the world. In a move to address this, [...]
Receive essential insights, resources and content direct to your inbox!
Hit subscribe to stay informed!
Advertisement
Latest News
Featured Webinars
Navigating the Clinical Outcomes Maze: An Overview of Clinical Outcomes Assessments and Why Training Matters
Tuesday, December 5, 2023
Sponsor: ICON
EU HTA Joint Clinical Assessments: Navigating Potential Challenges Ahead of 2025
Friday, November 10, 2023
Sponsor: OpenHealth
Cell & Gene Therapies – Beginning with the End in Mind
Thursday, November 2, 2023
Sponsor: Magnolia Market Access
Categories
Artificial Intelligence
Careers
Clinical Trials
Cost Effectiveness
Data Analytics & Syndicated Reports
Healthcare Financing
Health Databases
Health Equity
Health Policy
Health Tech Assessment
Integrated Evidence Assessment & Planning
Market Access
Medical Affairs
Patient Outcomes & Engagement
Pricing & Reimbursement
Real World Data
Real World Evidence
Value Assessment
Value Communication